Endurant Capital Management’s Pediatrix Medical MD Stock Holding History

Endurant Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-39,401	Closed	-$994K	–	55
2019 Q2	$994K	Buy	+39,401	New	+$1.06M	0.39%	44
2018 Q4	–	Sell	-20,959	Closed	-$978K	–	65
2018 Q3	$978K	Buy	20,959 +11,517	+122%	+$529K	0.44%	47
2018 Q2	$409K	Sell	9,442 -64,775	-87%	-$3.1M	0.18%	57
2018 Q1	$4.13M	Sell	74,217 -107,500	-59%	-$5.89M	1.54%	22
2017 Q4	$9.71M	Buy	181,717 +5,317	+3%	+$251K	2.97%	7
2017 Q3	$7.61M	Buy	+176,400	New	+$8.38M	2.3%	15
2016 Q3	–	Sell	-17,000	Closed	-$1.23M	–	100
2016 Q2	$1.23M	Buy	+17,000	New	+$1.17M	0.41%	49

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Endurant Capital Management's MD Position: Q3 2019 in Review

Endurant Capital Management sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 39,401 shares — an estimated $994K sold.

Endurant Capital Management first reported a position in MD in Q2 2016 and held it in 7 quarters. The position peaked at $9.71M in Q4 2017. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

Endurant Capital Management reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
Endurant Capital Management sold 39,401 Pediatrix Medical shares in Q3 2019, an estimated $994K.
Endurant Capital Management first reported a position in Pediatrix Medical in Q2 2016 and held it in 7 quarters.
Endurant Capital Management's Pediatrix Medical position peaked at $9.71M in Q4 2017.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Endurant Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.